O	0	6	Growth	Growth	NN	B-NP
O	7	12	state	state	NN	I-NP
O	12	13	-	-	HYPH	B-NP
O	13	22	dependent	dependent	JJ	I-NP
O	23	33	regulation	regulation	NN	I-NP
O	34	36	of	of	IN	B-PP
O	37	44	protein	protein	NN	B-NP
O	45	51	kinase	kinase	NN	I-NP
O	52	53	C	C	NN	I-NP
O	54	56	in	in	IN	B-PP
O	57	63	normal	normal	JJ	B-NP
O	64	67	and	and	CC	I-NP
O	68	79	transformed	transform	VBN	I-NP
O	80	86	murine	murine	JJ	I-NP
B-Cell	87	92	cells	cell	NNS	I-NP
O	92	93	.	.	.	O

O	95	97	We	We	PRP	B-NP
O	98	108	determined	determine	VBD	B-VP
O	109	116	whether	whether	IN	B-SBAR
O	117	123	growth	growth	NN	B-NP
O	124	129	state	state	NN	I-NP
O	130	133	can	can	MD	B-VP
O	134	143	influence	influence	VB	I-VP
O	144	147	the	the	DT	B-NP
O	148	154	action	action	NN	I-NP
O	155	157	of	of	IN	B-PP
O	158	165	protein	protein	NN	B-NP
O	166	172	kinase	kinase	NN	I-NP
O	173	174	C	C	NN	I-NP
O	175	177	by	by	IN	B-PP
O	178	187	measuring	measure	VBG	B-VP
O	188	195	protein	protein	NN	B-NP
O	196	202	kinase	kinase	NN	I-NP
O	203	204	C	C	NN	I-NP
O	205	213	activity	activity	NN	I-NP
O	214	216	in	in	IN	B-PP
O	217	224	growing	grow	VBG	B-NP
O	225	228	and	and	CC	I-NP
O	229	239	stationary	stationary	JJ	I-NP
B-Cell	240	248	cultures	culture	NNS	I-NP
O	249	251	of	of	IN	B-PP
O	252	258	normal	normal	JJ	B-NP
O	259	262	and	and	CC	I-NP
O	263	274	transformed	transform	VBN	I-NP
B-Cell	275	280	cells	cell	NNS	I-NP
O	280	281	.	.	.	O

O	282	285	Two	Two	CD	B-NP
O	286	296	approaches	approach	NNS	I-NP
O	297	301	were	be	VBD	B-VP
O	302	306	used	use	VBN	I-VP
O	307	309	to	to	TO	B-VP
O	310	317	measure	measure	VB	I-VP
O	318	325	protein	protein	NN	B-NP
O	326	332	kinase	kinase	NN	I-NP
O	333	334	C	C	NN	I-NP
O	334	335	:	:	:	O
O	336	341	assay	assay	NN	B-NP
O	342	344	of	of	IN	B-PP
O	345	351	intact	intact	JJ	B-NP
B-Cell	352	357	cells	cell	NNS	I-NP
O	358	361	for	for	IN	B-PP
O	362	372	inhibition	inhibition	NN	B-NP
O	373	375	of	of	IN	B-PP
O	376	385	epidermal	epidermal	JJ	B-NP
O	386	392	growth	growth	NN	I-NP
O	393	399	factor	factor	NN	I-NP
O	400	401	(	(	(	O
O	401	404	EGF	EGF	NN	B-NP
O	404	405	)	)	)	O
O	406	413	binding	binding	NN	B-NP
O	414	416	in	in	IN	B-PP
O	417	425	response	response	NN	I-PP
O	426	428	to	to	TO	I-PP
O	429	436	phorbol	phorbol	NN	B-NP
O	437	447	dibutyrate	dibutyrate	NN	I-NP
O	448	449	(	(	(	O
O	449	453	PDBu	PDBu	NN	B-NP
O	453	454	)	)	)	O
O	454	455	;	;	:	O
O	456	459	and	and	CC	O
O	460	465	assay	assay	NN	B-NP
O	466	468	of	of	IN	B-PP
O	469	478	detergent	detergent	JJ	B-NP
B-Organism_substance	479	487	extracts	extract	NNS	I-NP
O	488	491	for	for	IN	B-PP
O	492	497	total	total	JJ	B-NP
O	498	505	calcium	calcium	NN	I-NP
O	505	506	,	,	,	O
O	507	519	phospholipid	phospholipid	NN	B-NP
O	519	520	-	-	HYPH	B-NP
O	520	529	dependent	dependent	JJ	I-NP
O	530	536	kinase	kinase	NN	I-NP
O	537	545	activity	activity	NN	I-NP
O	545	546	.	.	.	O

O	547	549	In	In	IN	B-PP
B-Organism_substance	550	558	extracts	extract	NNS	B-NP
O	559	561	of	of	IN	B-PP
O	562	569	growing	grow	VBG	B-NP
O	570	573	and	and	CC	I-NP
O	574	584	stationary	stationary	JJ	I-NP
B-Cell	585	590	Swiss	Swiss	JJ	I-NP
I-Cell	591	594	3T3	3T3	NN	I-NP
I-Cell	595	600	cells	cell	NNS	I-NP
O	600	601	,	,	,	O
O	602	605	the	the	DT	B-NP
O	606	611	total	total	JJ	I-NP
O	612	618	amount	amount	NN	I-NP
O	619	621	of	of	IN	B-PP
O	622	629	protein	protein	NN	B-NP
O	630	636	kinase	kinase	NN	I-NP
O	637	638	C	C	NN	I-NP
O	639	647	activity	activity	NN	I-NP
O	648	651	was	be	VBD	B-VP
O	652	659	similar	similar	JJ	B-ADJP
O	659	660	,	,	,	O
O	661	671	indicating	indicate	VBG	B-VP
O	672	676	that	that	IN	B-SBAR
O	677	683	growth	growth	NN	B-NP
O	684	689	state	state	NN	I-NP
O	690	694	does	do	VBZ	B-VP
O	695	698	not	not	RB	I-VP
O	699	704	alter	alter	VB	I-VP
O	705	708	the	the	DT	B-NP
O	709	714	level	level	NN	I-NP
O	715	717	of	of	IN	B-PP
O	718	724	enzyme	enzyme	NN	B-NP
O	725	727	in	in	IN	B-PP
O	728	731	the	the	DT	B-NP
B-Cell	732	736	cell	cell	NN	I-NP
O	736	737	.	.	.	O

O	738	741	The	The	DT	B-NP
O	742	747	short	short	JJ	I-NP
O	747	748	-	-	HYPH	I-NP
O	748	752	term	term	NN	I-NP
O	753	761	response	response	NN	I-NP
O	762	764	of	of	IN	B-PP
B-Cell	765	770	Swiss	Swiss	JJ	B-NP
I-Cell	771	774	3T3	3T3	NN	I-NP
I-Cell	775	780	cells	cell	NNS	I-NP
O	781	783	to	to	TO	B-PP
O	784	786	an	an	DT	B-NP
O	787	796	activator	activator	NN	I-NP
O	797	799	of	of	IN	B-PP
O	800	807	protein	protein	NN	B-NP
O	808	814	kinase	kinase	NN	I-NP
O	815	816	C	C	NN	I-NP
O	817	821	also	also	RB	B-ADVP
O	822	830	appeared	appear	VBD	B-VP
O	831	833	to	to	TO	I-VP
O	834	836	be	be	VB	I-VP
O	837	848	independent	independent	JJ	B-ADJP
O	849	851	of	of	IN	B-PP
O	852	858	growth	growth	NN	B-NP
O	859	864	state	state	NN	I-NP
O	864	865	,	,	,	O
O	866	871	since	since	IN	B-SBAR
O	872	875	the	the	DT	B-NP
O	876	878	50	50	CD	I-NP
O	878	879	%	%	NN	I-NP
O	880	889	effective	effective	JJ	I-NP
O	890	894	dose	dose	NN	I-NP
O	895	898	for	for	IN	B-PP
O	899	903	PDBu	PDBu	NN	B-NP
O	904	914	inhibition	inhibition	NN	I-NP
O	915	917	of	of	IN	B-PP
O	918	921	EGF	EGF	NN	B-NP
O	922	929	binding	binding	NN	I-NP
O	930	932	to	to	TO	B-PP
O	933	936	its	its	PRP$	B-NP
O	937	945	receptor	receptor	NN	I-NP
O	946	949	was	be	VBD	B-VP
O	950	963	approximately	approximately	RB	B-NP
O	964	965	7	7	CD	I-NP
O	966	968	nM	nM	NN	I-NP
O	969	972	for	for	IN	B-PP
O	973	977	both	both	DT	B-NP
O	978	984	growth	growth	NN	I-NP
O	985	995	conditions	condition	NNS	I-NP
O	995	996	.	.	.	O

O	997	999	In	In	IN	B-PP
O	1000	1008	contrast	contrast	NN	B-NP
O	1008	1009	,	,	,	O
O	1010	1013	the	the	DT	B-NP
O	1014	1022	response	response	NN	I-NP
O	1023	1025	of	of	IN	B-PP
B-Cell	1026	1031	cells	cell	NNS	B-NP
O	1032	1034	to	to	TO	B-PP
O	1035	1039	long	long	JJ	B-NP
O	1039	1040	-	-	HYPH	I-NP
O	1040	1044	term	term	NN	I-NP
O	1045	1054	treatment	treatment	NN	I-NP
O	1055	1059	with	with	IN	B-PP
O	1060	1064	PDBu	PDBu	NN	B-NP
O	1065	1068	was	be	VBD	B-VP
O	1069	1082	significantly	significantly	RB	B-ADJP
O	1083	1092	different	different	JJ	I-ADJP
O	1093	1102	depending	depend	VBG	B-VP
O	1103	1107	upon	upon	IN	B-PP
O	1108	1111	the	the	DT	B-NP
O	1112	1119	initial	initial	JJ	I-NP
O	1120	1126	growth	growth	NN	I-NP
O	1127	1132	state	state	NN	I-NP
O	1133	1135	of	of	IN	B-PP
O	1136	1139	the	the	DT	B-NP
B-Cell	1140	1145	cells	cell	NNS	I-NP
O	1145	1146	.	.	.	O

O	1147	1149	In	In	IN	B-PP
O	1150	1154	both	both	DT	B-NP
O	1155	1161	growth	growth	NN	I-NP
O	1162	1168	states	state	NNS	I-NP
O	1168	1169	,	,	,	O
O	1170	1174	PDBu	PDBu	NN	B-NP
O	1175	1181	caused	cause	VBD	B-VP
O	1182	1186	loss	loss	NN	B-NP
O	1187	1189	of	of	IN	B-PP
O	1190	1197	protein	protein	NN	B-NP
O	1198	1204	kinase	kinase	NN	I-NP
O	1205	1206	C	C	NN	I-NP
O	1207	1215	activity	activity	NN	I-NP
O	1215	1216	,	,	,	O
O	1217	1222	which	which	WDT	B-NP
O	1223	1232	reflected	reflect	VBD	B-VP
O	1233	1234	a	a	DT	B-NP
O	1235	1239	loss	loss	NN	I-NP
O	1240	1242	in	in	IN	B-PP
O	1243	1250	protein	protein	NN	B-NP
O	1251	1255	mass	mass	NN	I-NP
O	1256	1258	as	as	IN	B-SBAR
O	1259	1269	determined	determine	VBN	B-VP
O	1270	1272	by	by	IN	B-PP
O	1273	1287	immunoblotting	immunoblotte	VBG	B-VP
O	1288	1292	with	with	IN	B-PP
B-Organism_substance	1293	1302	antiserum	antiserum	NN	B-NP
O	1303	1305	to	to	TO	B-PP
O	1306	1313	protein	protein	NN	B-NP
O	1314	1320	kinase	kinase	NN	I-NP
O	1321	1322	C	C	NN	I-NP
O	1322	1323	.	.	.	O

O	1324	1331	However	However	RB	B-ADVP
O	1331	1332	,	,	,	O
O	1333	1336	the	the	DT	B-NP
O	1337	1344	maximum	maximum	JJ	I-NP
O	1345	1353	decrease	decrease	NN	I-NP
O	1354	1364	approached	approach	VBD	B-VP
O	1365	1368	100	100	CD	B-NP
O	1368	1369	%	%	NN	I-NP
O	1370	1372	in	in	IN	B-PP
O	1373	1383	stationary	stationary	JJ	B-NP
B-Cell	1384	1392	cultures	culture	NNS	I-NP
O	1393	1399	versus	versus	IN	B-PP
O	1400	1413	approximately	approximately	RB	B-NP
O	1414	1416	75	75	CD	I-NP
O	1416	1417	%	%	NN	I-NP
O	1418	1420	in	in	IN	B-PP
O	1421	1428	growing	grow	VBG	B-NP
B-Cell	1429	1434	cells	cell	NNS	I-NP
O	1434	1435	.	.	.	O

O	1436	1443	Protein	Protein	NN	B-NP
O	1444	1450	kinase	kinase	NN	I-NP
O	1451	1452	C	C	NN	I-NP
O	1453	1459	levels	level	NNS	I-NP
O	1460	1462	in	in	IN	B-PP
O	1463	1470	several	several	JJ	B-NP
O	1471	1482	transformed	transform	VBN	I-NP
B-Cell	1483	1487	cell	cell	NN	I-NP
I-Cell	1488	1493	lines	line	NNS	I-NP
O	1494	1498	were	be	VBD	B-VP
O	1499	1506	subject	subject	JJ	B-ADJP
O	1507	1509	to	to	TO	B-PP
O	1510	1514	down	down	VB	B-VP
O	1515	1525	modulation	modulation	NN	B-NP
O	1526	1528	in	in	IN	B-PP
O	1529	1530	a	a	DT	B-NP
O	1531	1538	similar	similar	JJ	I-NP
O	1539	1545	growth	growth	NN	I-NP
O	1546	1551	state	state	NN	I-NP
O	1551	1552	-	-	HYPH	B-NP
O	1552	1561	dependent	dependent	JJ	I-NP
O	1562	1568	manner	manner	NN	I-NP
O	1568	1569	.	.	.	O

O	1570	1577	Further	Further	RB	B-ADVP
O	1577	1578	,	,	,	O
O	1579	1582	the	the	DT	B-NP
O	1583	1593	inhibition	inhibition	NN	I-NP
O	1594	1596	of	of	IN	B-PP
O	1597	1600	EGF	EGF	NN	B-NP
O	1601	1608	binding	binding	NN	I-NP
O	1609	1611	by	by	IN	B-PP
B-Cancer	1612	1617	tumor	tumor	NN	B-NP
O	1618	1627	promoters	promoter	NNS	I-NP
O	1628	1637	following	follow	VBG	B-PP
O	1638	1642	long	long	JJ	B-NP
O	1642	1643	-	-	HYPH	I-NP
O	1643	1647	term	term	NN	I-NP
O	1648	1657	treatment	treatment	NN	I-NP
O	1658	1660	of	of	IN	B-PP
B-Cell	1661	1666	Swiss	Swiss	JJ	B-NP
I-Cell	1667	1670	3T3	3T3	NN	I-NP
I-Cell	1671	1676	cells	cell	NNS	I-NP
O	1677	1681	with	with	IN	B-PP
O	1682	1686	PDBu	PDBu	NN	B-NP
O	1687	1691	also	also	RB	B-ADVP
O	1692	1698	varied	vary	VBD	B-VP
O	1699	1703	with	with	IN	B-PP
O	1704	1710	growth	growth	NN	B-NP
O	1711	1716	state	state	NN	I-NP
O	1716	1717	.	.	.	O

O	1718	1720	In	In	IN	B-PP
O	1721	1725	down	down	RB	B-ADVP
O	1726	1735	modulated	modulate	VBD	B-VP
O	1736	1743	growing	grow	VBG	B-NP
B-Cell	1744	1749	cells	cell	NNS	I-NP
O	1749	1750	,	,	,	O
O	1751	1755	PDBu	PDBu	NN	B-NP
O	1756	1762	caused	cause	VBD	B-VP
O	1763	1769	almost	almost	RB	B-NP
O	1770	1778	complete	complete	JJ	I-NP
O	1779	1789	inhibition	inhibition	NN	I-NP
O	1790	1792	of	of	IN	B-PP
O	1793	1796	EGF	EGF	NN	B-NP
O	1797	1804	binding	binding	NN	I-NP
O	1804	1805	,	,	,	O
O	1806	1813	whereas	whereas	IN	O
O	1814	1816	in	in	IN	B-PP
O	1817	1821	down	down	RB	B-ADVP
O	1822	1831	modulated	modulate	VBD	B-VP
O	1832	1842	stationary	stationary	JJ	B-NP
B-Cell	1843	1848	cells	cell	NNS	I-NP
O	1848	1849	,	,	,	O
O	1850	1857	minimal	minimal	JJ	B-NP
O	1858	1868	inhibition	inhibition	NN	I-NP
O	1869	1871	of	of	IN	B-PP
O	1872	1875	EGF	EGF	NN	B-NP
O	1876	1883	binding	binding	NN	I-NP
O	1884	1886	by	by	IN	B-PP
O	1887	1891	PDBu	PDBu	NN	B-NP
O	1892	1895	was	be	VBD	B-VP
O	1896	1904	observed	observe	VBN	I-VP
O	1904	1905	.	.	.	O

O	1906	1911	These	These	DT	B-NP
O	1912	1919	results	result	NNS	I-NP
O	1920	1927	suggest	suggest	VBP	B-VP
O	1928	1932	that	that	IN	B-SBAR
O	1933	1942	prolonged	prolong	VBN	B-NP
O	1943	1952	treatment	treatment	NN	I-NP
O	1953	1957	with	with	IN	B-PP
B-Cancer	1958	1963	tumor	tumor	NN	B-NP
O	1964	1973	promoters	promoter	NNS	I-NP
O	1974	1980	alters	alter	VBZ	B-VP
O	1981	1984	the	the	DT	B-NP
O	1985	1996	sensitivity	sensitivity	NN	I-NP
O	1997	1999	of	of	IN	B-PP
B-Cell	2000	2005	cells	cell	NNS	B-NP
O	2006	2008	to	to	TO	B-PP
O	2009	2019	activators	activator	NNS	B-NP
O	2020	2022	of	of	IN	B-PP
O	2023	2030	protein	protein	NN	B-NP
O	2031	2037	kinase	kinase	NN	I-NP
O	2038	2039	C	C	NN	I-NP
O	2040	2042	in	in	IN	B-PP
O	2043	2044	a	a	DT	B-NP
O	2045	2051	growth	growth	NN	I-NP
O	2052	2057	state	state	NN	I-NP
O	2057	2058	-	-	HYPH	B-NP
O	2058	2067	dependent	dependent	JJ	I-NP
O	2068	2074	manner	manner	NN	I-NP
O	2074	2075	.	.	.	O

